CClinicalTrials.gg
CompletedNCT02335450Updated Jun 2, 2021Results posted

Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case Series

An interventional study of Motivational Interviewing and Wristband physical activity monitor in Multiple Sclerosis, sponsored by Oakland University. Completed at 1 site in United States. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2021-06-02.

Sponsored by Oakland University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
19 Years and older
Sex
All
01

Study summary

This study evaluates the effectiveness of personalized physical activity coaching combined with the use of a physical activity monitor to support increased levels of daily physical activity in individuals with multiple sclerosis. All five participants will receive the intervention over the four week intervention phase.

Read the detailed description

Individuals with multiple sclerosis engage in less daily physical activity than the general population for a variety of reasons. This research project is intended to evaluate whether individualized coaching combined with the use of a Fitbit physical activity wristband monitor will improve physical activity levels in individuals with multiple sclerosis.

Following admission into the study, participants will be visited once a week for four weeks at home by a physical therapist. The participants in consultation with the physical therapist will set daily physical activity goals for the following week and the participants will be taught how to monitor their daily activity using a Fitbit physical activity wristband.

The goals of this study are to determine whether this intervention is effective in helping participants increase their levels of daily physical activity and their confidence that they can successfully engage in daily physical activity. In addition, there will be an evaluation of changes from pre-intervention to post-intervention in quality of life measures.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • exercise
  • motivational interviewing
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 5 is below the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Oakland University is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • must have a physician diagnosis of multiple sclerosis and deemed suitable for engaging in a physical activity program by their physician
  • must be ambulatory with or without an assistive device
  • must be able to speak and read English
  • must have a home computer or device capable of tracking and recording the daily Fitbit physical activity reports

Exclusion criteria

Exclusion Criteria:

  • participants will be excluded if any contraindications to engaging in independent exercise are identified during the intake examination by the physical therapist: cardiovascular issues or safety issues with walking.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Single Arm

    All five participants in the study will receive this intervention. The participants will be visited in their homes by a physical therapist once a week. The physical therapist will use a coaching technique called motivational interviewing to help the participant develop personal physical activity goals. The participant will discuss their physical activity challenges, and with the help of the physical therapist the participant will set up personal physical activity goals for the following week. The participant will be given a wristband physical activity monitor to wear during the day for four weeks to track their progress in meeting their activity goals.

    Behavioral: Motivational Interviewing · Device: Wristband physical activity monitor

Interventions

  • BehavioralMotivational Interviewing

    The participant will describe their unique physical activity challenges and their physical activity goals with the physical therapist. Using the technique of motivational interviewing, the physical therapist will work with the participant to help identify potential solutions to challenges and set realistic activity goals for the next week. Each week, the participant and the physical therapist will review the previous week's activity data, and the participant's reports of any challenges or problems they encountered in meeting their physical activity goals the previous week. The participant will identify new activity goals for the next week.

    Also known as: Coaching

  • DeviceWristband physical activity monitor

    The participant will wear a Fitbit wristband which will track the participant's daily steps and minutes of physical activity.

06

What researchers measure

Primary outcomes

  1. Total Steps Taken Over Course of the Study

    Wristband physical activity monitor recorded steps taken by participant over the 4 weeks of the study. No minimum or maximum. No baseline taken so cannot compare pre-intervention to post intervention.

    Time frame: 4 weeks

Secondary outcomes

  1. Exercise Self-Efficacy Questionnaire

    The "Exercise Self-Efficacy Scale" is the participant's self-reported confidence in their ability to engage in exercise throughout the day. Each of the 6 items is scored from 0% confidence to 100% confidence. All items are summed and the score is divided by 6 Minimum score: 0 Maximum score:100 Higher scores mean a better outcome.

    Time frame: baseline and at end of 4-week intervention

  2. Multiple Sclerosis Self-Efficacy Scale

    The "Multiple Sclerosis Self-Efficacy Scale" is a self-report of impact of multiple sclerosis on quality of life. The 14 statements are answered by selecting one of six options from strongly disagree to strongly agree. Minimum value: 14 Maximum value: 84 Higher scores reflect mean a better outcome.

    Time frame: baseline compared to end of 4-week study

  3. Multiple Sclerosis Impact Scale

    The "Multiple Sclerosis Impact Scale" is a self-report on how multiple sclerosis has impacted day-to-day life during the past 2 weeks. The 29 items are graded by the participants on a 5 point scale rating from "not at all" to "extremely". Minimum score: 29 Maximum Score:145 Higher scores mean worse outcome.

    Time frame: baseline compared to end of 4-week study

07

Results

Posted Aug 13, 2020
Limitations and caveats
This was a small case series qualitative design study.

Participant flow

Participant flow — Overall Study
MilestoneSingle Arm
Started5
Completed4
Not completed1
Withdrew: Pregnancy1

Outcome measures

PrimaryTotal Steps Taken Over Course of the Study

Wristband physical activity monitor recorded steps taken by participant over the 4 weeks of the study. No minimum or maximum. No baseline taken so cannot compare pre-intervention to post intervention.

Time frame:
4 weeks
Reported as:
Number · steps over 4 weeks
Total Steps Taken Over Course of the Study
steps over 4 weeksSingle Arm
Total Steps Taken Over Course of the Study296,147
SecondaryExercise Self-Efficacy Questionnaire

The "Exercise Self-Efficacy Scale" is the participant's self-reported confidence in their ability to engage in exercise throughout the day. Each of the 6 items is scored from 0% confidence to 100% confidence. All items are summed and the score is divided by 6 Minimum score: 0 Maximum score:100 Higher scores mean a better outcome.

Time frame:
baseline and at end of 4-week intervention
Reported as:
Mean · score on a scale
Exercise Self-Efficacy Questionnaire
score on a scaleSingle Arm Mean Baseline ScoreSingle Arm Mean Post-study Score
Exercise Self-Efficacy Questionnaire73.65 (58.30 to 100)91.75 (77.00 to 100)
SecondaryMultiple Sclerosis Self-Efficacy Scale

The "Multiple Sclerosis Self-Efficacy Scale" is a self-report of impact of multiple sclerosis on quality of life. The 14 statements are answered by selecting one of six options from strongly disagree to strongly agree. Minimum value: 14 Maximum value: 84 Higher scores reflect mean a better outcome.

Time frame:
baseline compared to end of 4-week study
Reported as:
Mean · score on a scale
Multiple Sclerosis Self-Efficacy Scale
score on a scaleSingle Arm Mean Baseline ScoreSingle Arm Mean Post-study Score
Multiple Sclerosis Self-Efficacy Scale48.25 (40 to 69)47.25 (28 to 66)
SecondaryMultiple Sclerosis Impact Scale

The "Multiple Sclerosis Impact Scale" is a self-report on how multiple sclerosis has impacted day-to-day life during the past 2 weeks. The 29 items are graded by the participants on a 5 point scale rating from "not at all" to "extremely". Minimum score: 29 Maximum Score:145 Higher scores mean worse outcome.

Time frame:
baseline compared to end of 4-week study
Reported as:
Mean · score on a scale
Multiple Sclerosis Impact Scale
score on a scaleSingle Arm Baseline Mean ScoreSingle Arm Post-study Mean Score
Multiple Sclerosis Impact Scale78.25 (37 to 109)65 (34 to 77)

Adverse events

Collected over 5 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Single Arm0/5 (0%)0/5 (0%)0/5 (0%)

Baseline characteristics

All 5 participants completed baseline questionnaires.

Age, Continuous
Age, Continuous(years)Single Arm
Mean53 (36 to 69)
Sex: Female, Male
Sex: Female, Male(Participants)Single Arm
Female5
Male0
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Single Arm
Region of Enrollment
Region of Enrollment(participants)Single Arm
United States5
Exercise Self-Efficacy
Exercise Self-Efficacy(units on a scale)Single Arm
Mean72.58 (58.3 to 100.00)
Multiple Sclerosis Impact Scale
Multiple Sclerosis Impact Scale(units on a scale)Single Arm
Mean73.8 (37.0 to 109.0)
Multiple Sclerosis Self-Efficacy Scale
Multiple Sclerosis Self-Efficacy Scale(units on a scale)Single Arm
Mean51.4 (40.0 to 69.0)
08

Study locations

1 site
  • Oakland University
    Rochester, Michigan 48309, United States
09

References and documents

Publications

  • Borkoles E, Nicholls AR, Bell K, Butterly R, Polman RC. The lived experiences of people diagnosed with multiple sclerosis in relation to exercise. Psychol Health. 2008;23(4):427-41. doi: 10.1080/14768320701205309. PubMed 25160577 ↗
  • Stroud N, Minahan C, Sabapathy S. The perceived benefits and barriers to exercise participation in persons with multiple sclerosis. Disabil Rehabil. 2009;31(26):2216-22. doi: 10.3109/09638280902980928. PubMed 19903131 ↗
  • Stroud NM, Minahan CL. The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes. 2009 Jul 20;7:68. doi: 10.1186/1477-7525-7-68. PubMed 19619337 ↗
  • Rimmer JH, Riley B, Wang E, Rauworth A, Jurkowski J. Physical activity participation among persons with disabilities: barriers and facilitators. Am J Prev Med. 2004 Jun;26(5):419-25. doi: 10.1016/j.amepre.2004.02.002. PubMed 15165658 ↗
  • Brown C, Kitchen K, Nicoll K. Barriers and facilitators related to participation in aquafitness programs for people with multiple sclerosis: a pilot study. Int J MS Care. 2012 Fall;14(3):132-41. doi: 10.7224/1537-2073-14.3.132. PubMed 24453744 ↗
  • Motl RW, McAuley E, Sandroff BM. Longitudinal change in physical activity and its correlates in relapsing-remitting multiple sclerosis. Phys Ther. 2013 Aug;93(8):1037-48. doi: 10.2522/ptj.20120479. Epub 2013 Apr 18. PubMed 23599354 ↗
  • Motl RW, McAuley E, Snook EM. Physical activity and multiple sclerosis: a meta-analysis. Mult Scler. 2005 Aug;11(4):459-63. doi: 10.1191/1352458505ms1188oa. PubMed 16042230 ↗
  • McGuigan C, Hutchinson M. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):266-9. PubMed 14742602 ↗
  • Rigby SA, Domenech C, Thornton EW, Tedman S, Young CA. Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale. Mult Scler. 2003 Feb;9(1):73-81. doi: 10.1191/1352458503ms870oa. PubMed 12617272 ↗
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB. PubMed 12900694 ↗
  • Marcus BH, Selby VC, Niaura RS, Rossi JS. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport. 1992 Mar;63(1):60-6. doi: 10.1080/02701367.1992.10607557. PubMed 1574662 ↗
  • O'Halloran PD, Blackstock F, Shields N, Holland A, Iles R, Kingsley M, Bernhardt J, Lannin N, Morris ME, Taylor NF. Motivational interviewing to increase physical activity in people with chronic health conditions: a systematic review and meta-analysis. Clin Rehabil. 2014 Dec;28(12):1159-71. doi: 10.1177/0269215514536210. Epub 2014 Jun 18. PubMed 24942478 ↗

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication

Supporting information: Study protocol, Sap, Icf, Csr

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02335450
Lead sponsor
Oakland University
Responsible party
Beth Black (Asst Prof Physical Therapy, Health Sciences, Oakland University) — Principal investigator
First posted
Jan 9, 2015
Start date
Feb 12, 2015
Primary completion
Nov 12, 2015
Completion
Nov 12, 2015
Results posted
Aug 13, 2020
Last update
Jun 2, 2021

Study contacts

Beth Black, DSc
principal investigator · Oakland University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion